News Quantified

BNTX – biontech se - american depositary shares (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026

BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026

BioNTech (NASDAQ:BNTX) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $113.00 price target on the stock.

Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline [Yahoo! Finance]

BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer

-3.8%

MISS

1.1%

MISS

-3.3%

BEAT

-1.9%

BEAT

Leerink Partners

Form 144 BioNTech SE Filed by: Medine GmbH

Form 6-K BioNTech SE For: Jan 28

Form 6-K BioNTech SE For: Jan 13

Form 6-K BioNTech SE For: Jan 12

Form 6-K BioNTech SE For: Jan 06

Top News Gainers

3/17 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine 57.1%

3/18 BioNTech (BNTX) Skyrockets on Coronavirus Vaccine Hopes; One Analyst Remains Cautious [Yahoo! Finance News] 30.5%

4/22 Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2020 - ResearchAndMarkets.com 26.6%

3/16 BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat 25.1%

11/4 BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Bank of America Corp. They set a "buy" rating and a $21.00 price target on the stock. 12.2%

1/3 Global Novel Vaccine Delivery Devices Industry Report 2019-2030 10.6%

2/3 BioNTech Announces Commencement of Public Offering of American Depositary Shares 9.7%

1/6 Genevant Sciences to Present at Biotech Showcase 2020 9.4%

3/26 Detailed Insights into In Silico/Computer-Aided Drug Discovery Services Market to 2030 - Elaborate Profiles of Key Industry Players - ResearchAndMarkets.com 8.6%

12/6 Precision Medicine Market: Industry Analysis and Detailed Profiles of Neon Therapeutics, Moderna, Inc, Merck & Co., Inc, Bayer AG, PERSONALIS INC, GENOCEA BIOSCIENCES, INC | Data Bridge Market Research 8.4%

Top News Decliners

3/18 German Billionaire Twins’ Investment In Biotech Firm Surges After Deal With Pfizer On Coronavirus Vaccine [Forbes] -35.5%

3/19 Search for Coronavirus Vaccine Becomes a Global Competition [The New York Times] -23.1%

10/23 Global Personalized Cancer Vaccine Market, Clinical Trials & Future Outlook 2026 - ResearchAndMarkets.com -17.3%

4/22 Form 6-K BioNTech SE For: Apr 22 -15.7%

4/6 BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $59.00 price target on the stock. -15.6%

4/23 Pfizer Targets Summer For COVID-19 Vaccine Human Trials; Potential Treatment Also In The Works. [The Motley Fool] -14.1%

10/10 BioNTech Announces Pricing of Initial Public Offering -13.7%

3/16 BioNTech up 55% premarket on advancement of coronavirus vaccine [Seeking Alpha] -13.4%

4/9 Global Pharma, Biotech & Diagnostics Co-promotion & Co-marketing Partnering Terms & Agreements Report, 2014-2020 -11.7%

1/16 BioNTech to acquire Neon to strengthen global leadership position in T cell therapies -11.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day